Recombinant Enterococcus faecalis UPF0272 protein EF_1827 (EF_1827)

Shipped with Ice Packs
In Stock

Description

Introduction to Enterococcus faecalis and EF_1827

Enterococcus faecalis is a Gram-positive, facultative anaerobic bacterium that inhabits the gastrointestinal tracts of humans and animals . While it can act as a probiotic or starter in food production, certain strains have emerged as nosocomial pathogens due to antibiotic resistance and virulence factors .

The protein EF_1827 is annotated as a UPF0272 protein within E. faecalis. Proteins within the UPF0272 family are conserved in bacteria, but their precise function is currently unknown.

Recombinant Production of EF_1827

Recombinant DNA technology allows for the production of E. faecalis proteins, such as EF_1827, in heterologous hosts like E. coli . This involves cloning the EF_1827 gene into an expression vector and introducing it into E. coli for protein synthesis. Recombinant proteins are often produced with a polyhistidine tag (His-tag), which facilitates purification using affinity chromatography .

Predicted Features of EF_1827

Due to the limited characterization of UPF0272 proteins, functional predictions are largely based on bioinformatics analyses. These analyses suggest the following:

  • Conserved hypothetical protein The EF_1827 protein belongs to the UPF0272 family, which includes proteins that are highly conserved across different bacterial species but lack a known function .

  • Potential role in stress response Some studies suggest that UPF0272 proteins may be involved in bacterial stress responses, such as those related to changes in temperature, pH, or nutrient availability.

  • Possible involvement in virulence In pathogenic bacteria, hypothetical proteins have been found to contribute to virulence, though this has not been confirmed for EF_1827.

Research Applications

Recombinant EF_1827 protein could be used in various research applications:

  • Structural studies Determining the three-dimensional structure of EF_1827 could provide insights into its potential function.

  • Interaction studies Identifying proteins that interact with EF_1827 in E. faecalis could help elucidate its role in cellular processes.

  • Functional assays Developing biochemical assays to test the activity of EF_1827 may reveal its enzymatic or regulatory properties.

  • Antibody development Recombinant EF_1827 can be used to generate antibodies for detecting the protein in E. faecalis cells and tissues.

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, serving as a guideline for your use.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer components, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us; we will prioritize its development.
Synonyms
EF_1827Putative nickel insertion protein
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-326
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Enterococcus faecalis (strain ATCC 700802 / V583)
Target Names
EF_1827
Target Protein Sequence
MNDRFVCSLI EKSDLSNFVK KHSKNVFYDI AKAEAAVHQQ TIDTIHFHEV GAIDSIVDIV GFFILWEQLE IEQVYSTPIT DGSGTITIAH GVMPIPVPAV MELRKETNLI IQQDFEIKTE LVTPTGLAIF KELSPLFVAP EQRLIEKIGY GFGKRETGKF NALRGSIFTE THSKKKRTEH HDQVLKIETN IDNQTPEQLG YVMDLLLEHG ALDVFFTPIH MKKNRSAILL TVLTTTEEKE YFTELLFKHT STIGMRFQTM ERSVMDRSFK ILETPFGKVH IKKNHYHGLL KESIEYQDCE RIAKQYNFTI EEVYRLVQTL NNKTID
Uniprot No.

Q&A

What is Recombinant Enterococcus faecalis UPF0272 protein EF_1827 and how is it typically produced?

Recombinant Enterococcus faecalis UPF0272 protein EF_1827 is typically produced using E. coli expression systems. Based on similar E. faecalis recombinant proteins, the expression construct generally includes an N-terminal methionine and a 6-His tag to facilitate purification . The protein is commonly expressed with specific amino acid boundaries (similar to the Glu29-Lys1324 range seen in other E. faecalis proteins) to ensure proper folding and function .

The expression methodology involves:

  • Cloning the UPF0272 protein EF_1827 gene into an appropriate expression vector

  • Transforming the construct into competent E. coli cells

  • Inducing protein expression under optimized conditions

  • Lysing cells and purifying using nickel affinity chromatography

  • Confirming identity and purity through SDS-PAGE and Western blotting

How should Recombinant Enterococcus faecalis UPF0272 protein EF_1827 be stored to maintain stability?

For maximum stability and activity retention, Recombinant Enterococcus faecalis UPF0272 protein EF_1827 should be stored following these guidelines:

  • Use a manual defrost freezer and avoid repeated freeze-thaw cycles

  • Store the protein immediately upon receipt at the recommended temperature (typically -20°C to -80°C for long-term storage)

  • For carrier-free preparations, consider aliquoting the protein into single-use volumes before freezing to prevent repeated freeze-thaw cycles

  • If the protein is formulated in a buffer with glycerol, storage at -20°C may be suitable

The typical formulation for E. faecalis recombinant proteins is as a 0.2 μm filtered solution in Tris and NaCl buffer . When shipping is required, the protein should be transported with polar packs to maintain cold chain integrity .

What assay methods are recommended for measuring the activity of Recombinant Enterococcus faecalis UPF0272 protein EF_1827?

While specific assays for UPF0272 protein EF_1827 would depend on its biochemical function, a general enzymatic activity assay protocol can be adapted from similar E. faecalis proteins:

Materials required:

  • Assay Buffer: 0.1 M MES, pH 6.0 (adjust pH based on optimal conditions for UPF0272)

  • Recombinant Enterococcus faecalis UPF0272 protein EF_1827

  • Appropriate substrate (determined by protein function)

  • Clear 96-well plate

  • Plate reader

General Procedure:

  • Dilute the protein to 1 μg/mL in assay buffer

  • Prepare substrate solution at appropriate concentration

  • Add 50 μL of diluted protein to plate wells

  • Start the reaction by adding 50 μL of substrate solution

  • Include appropriate controls (substrate blank, positive control)

  • Incubate at room temperature for the optimal time period

  • Add stop solution if required

  • Measure appropriate readout (absorbance, fluorescence, etc.)

  • Calculate specific activity using the formula:

Specific Activity (pmol/min/μg) =Adjusted Measurement × well volume (L) × 10¹² pmol/mol
Incubation time (min) × extinction coefficient (M⁻¹cm⁻¹) × path correction (cm) × amount of enzyme (μg)

This general protocol should be optimized for the specific biochemical properties of UPF0272 protein EF_1827 .

How can I design a robust experimental protocol to characterize protein-protein interactions involving Recombinant Enterococcus faecalis UPF0272 protein EF_1827?

Designing protein-protein interaction studies for UPF0272 protein EF_1827 requires a multi-technique approach:

1. Preliminary Binding Studies:

  • Pull-down assays using the His-tag on the recombinant protein

  • Co-immunoprecipitation with suspected binding partners

  • ELISA-based binding assays to quantify interactions

2. Biophysical Characterization:

  • Surface Plasmon Resonance (SPR) to determine kinetic parameters (kon, koff, KD)

  • Isothermal Titration Calorimetry (ITC) for thermodynamic parameters

  • Size Exclusion Chromatography with Multi-Angle Light Scattering (SEC-MALS) to analyze complex formation

3. Experimental Design Considerations:

  • Include proper controls (non-specific proteins, buffer-only controls)

  • Test interactions under varying conditions (pH, ionic strength, temperature)

  • Consider the carrier-free version of the protein when interference from carrier proteins might affect results

  • Use multiple complementary techniques to validate interaction findings

4. Data Analysis Framework:

  • Fit binding data to appropriate models (1:1 binding, cooperative binding)

  • Calculate and report affinity constants with confidence intervals

  • Validate results with orthogonal methods

This approach aligns with true experimental research design principles by incorporating controls, variable manipulation, and statistical analysis .

How can researchers address inconsistent activity or degradation issues with Recombinant Enterococcus faecalis UPF0272 protein EF_1827?

When facing inconsistent activity or degradation of UPF0272 protein EF_1827, implement this systematic troubleshooting approach:

Stability Assessment:

  • Analyze protein stability by SDS-PAGE at different time points and storage conditions

  • Perform activity assays with freshly thawed aliquots versus samples subjected to various handling conditions

  • Check for aggregation using dynamic light scattering

Buffer Optimization:

  • Test stability in different buffer compositions (vary pH, salt concentration, and additives)

  • Consider adding protective agents such as glycerol, non-ionic detergents, or specific cofactors

  • For carrier-free preparations, evaluate if adding a carrier protein (e.g., BSA) improves stability

Handling Protocol Refinement:

  • Minimize freeze-thaw cycles by creating single-use aliquots

  • Maintain cold chain integrity during all handling steps

  • Use low-binding tubes and pipette tips to prevent protein loss

  • Pre-coat surfaces with BSA when working with very dilute protein solutions

Documentation and Standardization:

  • Implement detailed record-keeping of lot numbers, storage conditions, and handling procedures

  • Standardize protein concentration determination methods

  • Include internal controls in each experiment to normalize for batch-to-batch variation

This methodological approach addresses both the immediate troubleshooting needs and establishes practices to prevent future issues.

What statistical approaches are recommended for analyzing dose-response data from experiments using Recombinant Enterococcus faecalis UPF0272 protein EF_1827?

1. Data Preparation:

  • Transform data if necessary to meet parametric test assumptions

  • Identify and address outliers using standardized methods (e.g., Grubbs' test)

  • Normalize data to appropriate controls

2. Curve Fitting:

  • Fit data to appropriate models (e.g., four-parameter logistic model for sigmoidal responses)

  • Calculate EC50/IC50 values with 95% confidence intervals

  • Compare goodness-of-fit between different models (AIC, BIC criteria)

3. Statistical Testing Framework:

  • Use ANOVA with post-hoc tests for comparing multiple concentrations

  • Implement regression analysis to determine dose-dependency

  • Apply non-parametric alternatives when assumptions aren't met

4. Validation and Reporting:

  • Perform power analysis to ensure adequate sample size

  • Report effect sizes alongside p-values

  • Include detailed methods for replicability

Example Statistical Analysis Table:

ParameterAnalysis MethodReporting FormatSoftware Tool
Dose-dependencyLinear or non-linear regressionSlope with 95% CI, R²GraphPad Prism
EC50/IC504-parameter logistic modelValue with 95% CIGraphPad Prism/R
Between-group differencesOne-way ANOVA with Tukey's post-hocF-statistic, p-value, effect sizeSPSS/R
Non-normal dataKruskal-Wallis with Dunn's post-hocH-statistic, p-valueSPSS/R

This framework aligns with experimental research design principles by emphasizing statistical rigor and appropriate methodology .

How does Recombinant Enterococcus faecalis UPF0272 protein EF_1827 compare functionally to orthologous proteins from other bacterial species?

Comparing UPF0272 protein EF_1827 to orthologous proteins requires a systematic approach:

Bioinformatic Analysis:

  • Perform sequence alignment using tools like MUSCLE or Clustal Omega

  • Calculate sequence identity and similarity percentages

  • Identify conserved domains and motifs

  • Construct phylogenetic trees to visualize evolutionary relationships

Structural Comparison:

  • Generate homology models if experimental structures aren't available

  • Analyze structural conservation of active sites and binding pockets

  • Compare electrostatic surface potentials

  • Evaluate dynamics through molecular dynamics simulations

Functional Assessment:

  • Design parallel activity assays to test orthologous proteins under identical conditions

  • Compare kinetic parameters (Km, kcat, kcat/Km)

  • Assess substrate specificity profiles

  • Evaluate stability under different environmental conditions

Physiological Context:

  • Compare expression patterns in native organisms

  • Analyze genomic context and potential operon structures

  • Review literature for species-specific functions

This comprehensive approach provides insights into both the conserved and divergent aspects of UPF0272 protein function across bacterial species.

What are the recommended experimental designs for investigating the role of Recombinant Enterococcus faecalis UPF0272 protein EF_1827 in bacterial pathogenesis?

Investigating UPF0272 protein EF_1827's role in pathogenesis requires a multi-faceted experimental approach:

In Vitro Models:

  • Cell culture infection models using wild-type and UPF0272 knockout strains

  • Adhesion and invasion assays with epithelial cell lines

  • Immune cell stimulation assays (cytokine production, phagocytosis)

  • Biofilm formation comparison between wild-type and mutant strains

Molecular Mechanism Studies:

  • Protein-protein interaction studies with host factors

  • Subcellular localization during infection (immunofluorescence)

  • Transcriptomic analysis of host cells in response to purified protein

  • Signal pathway activation studies in host cells

In Vivo Models:

  • Infection models with wild-type vs. UPF0272 knockout strains

  • Complementation studies to confirm phenotype specificity

  • Tissue-specific colonization and dissemination studies

  • Immune response characterization

Experimental Design Framework:

  • True experimental design with proper controls (wild-type, knockout, complemented strains)

  • Randomization of experimental units where applicable

  • Blinding of analysis when possible

  • Adequate biological and technical replication

This comprehensive approach combines in vitro and in vivo methods to establish causality between UPF0272 protein activity and pathogenesis mechanisms.

What purification strategy is optimal for obtaining high-purity Recombinant Enterococcus faecalis UPF0272 protein EF_1827 for structural studies?

For structural studies requiring ultra-pure protein preparations, implement this optimized purification strategy:

Primary Purification:

  • Immobilized metal affinity chromatography (IMAC) using the N-terminal 6-His tag

  • Optimize binding and elution conditions (buffer composition, imidazole gradient)

  • Include reducing agents if the protein contains cysteines

Secondary Purification:

  • Size exclusion chromatography to remove aggregates and ensure monodispersity

  • Ion exchange chromatography for removing co-purifying contaminants

  • Consider affinity tag removal using specific proteases if the tag interferes with structural studies

Quality Control:

  • Assess purity by SDS-PAGE (aim for >95% purity)

  • Confirm identity by mass spectrometry

  • Verify homogeneity by dynamic light scattering

  • Assess activity using functional assays

  • Determine protein concentration by multiple methods (Bradford, BCA, A280)

Final Preparation:

  • Buffer exchange into a structural biology-compatible buffer

  • Concentrate to required concentration while monitoring for aggregation

  • Flash-freeze aliquots in liquid nitrogen or proceed directly to structural studies

  • For carrier-free preparations, implement strategies to prevent adsorption to surfaces

This methodical approach ensures the highest quality protein preparation suitable for demanding structural biology applications such as X-ray crystallography, cryo-EM, or NMR.

How can researchers design experiments to resolve contradictory findings about the enzymatic activity of Recombinant Enterococcus faecalis UPF0272 protein EF_1827?

When faced with contradictory findings regarding enzymatic activity, implement this systematic resolution approach:

Systematic Variable Control:

  • Standardize protein source and preparation methods

  • Use the same batch of substrate and reagents across comparison experiments

  • Control environmental conditions (temperature, pH, ionic strength)

  • Implement precise timing protocols for reaction components

Comprehensive Method Comparison:

  • Perform parallel assays using different detection methods

  • Vary protein and substrate concentrations systematically

  • Test activity under different buffer conditions

  • Compare carrier-free versus carrier-containing preparations

Statistical Rigor:

  • Increase sample size and replication to improve statistical power

  • Apply appropriate statistical tests for comparing methods

  • Calculate measurement uncertainty for each method

  • Use Bland-Altman plots to analyze agreement between methods

Collaborative Validation:

  • Engage independent laboratories to perform identical protocols

  • Share reagents between groups to eliminate preparation variables

  • Implement double-blind testing where appropriate

  • Document all experimental parameters meticulously

This experimental approach follows true experimental research design principles by systematically controlling variables and implementing statistical validation , ultimately resolving contradictions through methodological rigor rather than assumption.

What are the emerging applications of Recombinant Enterococcus faecalis UPF0272 protein EF_1827 in microbiome research?

Emerging applications of UPF0272 protein EF_1827 in microbiome research span several innovative areas:

Host-Microbe Interaction Studies:

  • Investigation of UPF0272's role in bacterial colonization of mucosal surfaces

  • Analysis of its potential interactions with host immunity factors

  • Examination of its contribution to microbiome stability or dysbiosis

  • Development of UPF0272-targeted approaches to modulate microbiome composition

Functional Microbiome Analysis:

  • Use of UPF0272 activity as a functional biomarker for specific microbiome states

  • Correlation of UPF0272 presence/activity with metabolomic profiles

  • Integration into multi-omics approaches for comprehensive microbiome characterization

  • Application in longitudinal studies tracking microbiome functional changes

Therapeutic Development Avenues:

  • Exploration of UPF0272 as a target for microbiome-modulating therapeutics

  • Investigation of its potential as a biomarker for treatment response

  • Development of UPF0272-based diagnostic tools for microbiome assessment

  • Consideration of UPF0272 in precision microbiome medicine approaches

Methodological Advancements:

  • Development of UPF0272-specific tools for functional microbiome research

  • Integration into microbiome model systems (gut-on-a-chip, organoids)

  • Application in culturomic approaches for enhanced microbiome cultivation

  • Implementation in microbiome synthetic biology efforts

These emerging applications represent the cutting edge of UPF0272 protein research in the rapidly evolving microbiome field.

What experimental methods are recommended for studying the structural dynamics of Recombinant Enterococcus faecalis UPF0272 protein EF_1827?

Studying structural dynamics of UPF0272 protein EF_1827 requires a multi-technique approach:

Solution-Phase Techniques:

Spectroscopic Methods:

  • Circular dichroism (CD) spectroscopy for secondary structure changes

    • Monitor thermal transitions to identify stability changes

    • Perform titration experiments with potential ligands

    • Apply deconvolution algorithms to quantify structural components

  • Fluorescence spectroscopy for tertiary structure dynamics

    • Utilize intrinsic tryptophan fluorescence or introduced labels

    • Perform quenching experiments to probe accessibility

    • Measure anisotropy to detect changes in rotational freedom

Computational Approaches:

  • Molecular dynamics simulations to predict dynamic behavior

    • Run multiple simulations with varying starting conditions

    • Analyze principal components of motion

    • Identify potential allosteric networks

  • Normal mode analysis for identifying large-scale motions

    • Focus on low-frequency modes most relevant to function

    • Compare results with experimental data

    • Generate visualizations of predicted motions

This comprehensive approach provides complementary insights into protein dynamics from different perspectives, offering a more complete understanding of UPF0272 protein EF_1827's structural flexibility and function.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.